시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 알부테롤 황산염 정량 흡입기 시장 보고서(2025년)
Albuterol Sulfate Metered Dose Inhalers Global Market Report 2025
상품코드 : 1760453
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

알부테롤 황산염 정량 흡입기 시장 규모는 향후 수 년간 강력한 성장이 전망될 예정입니다. 기관에 의한 계발 캠페인의 고조, 호흡기 알레르기의 유병률의 상승 등에 기인하고 있습니다. 예측 기간 중의 주요 동향에는 효능을 향상시키기 위한 약제 배합의 진보, 디지털 용량 추적 시스템의 임베디드, 일관된 투여를 위한 선진적 제조 기술의 사용, 친환경 추진제의 혁신, 원격 의료와 흡입기 사용의 통합 등이 있습니다.

호흡기 질환의 유병률 증가는 알부테롤 황산염 정량 흡입기 시장의 확대를 촉진할 것으로 예측됩니다. 폐질환(COPD), 폐렴, 기관지염 및 기타 폐 감염이 포함됩니다. 알부테롤 황산염 정량 흡입기는 기도의 근육을 이완시키고, 기류를 촉진하고, 호흡을 편하게 함으로써 증상을 완화합니다. 계국에 따르면 호주에서 COPD의 유병률은 2021년의 2.4%에서 2022년에는 2.5%로 증가했습니다.

알부테롤 황산염 정량 흡입기 시장의 주요 기업은 만성 호흡기 질환을 앓고 있는 사람들의 접근성을 높이기 위해 제네릭 흡입 제품을 포함한 첨단 솔루션의 개발을 우선시하고 있습니다. 이 제네릭 흡입제는 브랜드 제품과 동일한 활성 성분, 복용량 및 치료 효과를 제공하지만 일반적으로 더 저렴한 가격입니다. 예를 들어, 2024년 5월 미국 제약회사인 암파스터 퍼머슈티컬즈는 알부테롤 황산염 정량 흡입기에 대한 식품의약국(FDA)으로부터 간략한 신약 승인 신청(ANDA)을 취득했습니다. 이 제품은 4세 이상 환자의 기관지 경련을 치료하거나 예방하기 위해 고안되었습니다. 이 약은 기도 근육을 이완시키고 기류를 개선하며 천식 환자의 천명과 호흡 곤란과 같은 증상을 신속하게 완화합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나연과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

SHW
영문 목차

영문목차

Albuterol sulfate metered dose inhalers (MDIs) are compact devices designed to deliver a precise dose of albuterol sulfate directly into the lungs, helping to relax airway muscles, improve airflow, and provide quick relief from breathing difficulties. These inhalers are primarily used to manage and alleviate symptoms of respiratory conditions.

The main types of albuterol sulfate metered dose inhalers include pressurized metered dose inhalers (pMDIs) and breath-activated metered dose inhalers. Pressurized metered-dose inhalers (pMDIs) are portable devices that release an aerosolized dose of medication to the lungs, providing rapid relief for respiratory conditions. These inhalers come in various formulations, including single-unit and multiple-unit dose inhalers. They are distributed through various channels, such as hospital pharmacies, retail pharmacies, online pharmacies, and others, and are used for treating conditions such as asthma, chronic obstructive pulmonary disease (COPD), and more.

The albuterol sulfate metered dose inhalers market research report is one of a series of new reports from The Business Research Company that provides albuterol sulfate metered dose inhalers market statistics, including the albuterol sulfate metered dose inhalers industry global market size, regional shares, competitors with the albuterol sulfate metered dose inhalers market share, detailed albuterol sulfate metered dose inhalers market segments, market trends, and opportunities, and any further data you may need to thrive in the albuterol sulfate metered dose inhalers industry. This albuterol sulfate metered dose inhalers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The albuterol sulfate metered dose inhalers market size has grown strongly in recent years. It will grow from $4.78 billion in 2024 to $5.20 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth during the historic period can be attributed to increased awareness of respiratory health, higher adoption of fast-relief bronchodilators, rising demand for portable inhalation devices, a surge in respiratory emergencies, and a growing number of approvals for generic inhalers.

The albuterol sulfate metered dose inhalers market size is expected to see strong growth in the next few years. It will grow to $7.19 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to the rising demand for cost-effective treatment options, a growing emphasis on preventive respiratory care, increasing investments in inhaler innovation, heightened awareness campaigns by health organizations, and the rising prevalence of respiratory allergies. Major trends during the forecast period include advancements in drug formulation to improve efficacy, the incorporation of digital dose tracking systems, the use of advanced manufacturing techniques for consistent dosing, innovations in environmentally friendly propellants, and the integration of telemedicine with inhaler usage.

The growing prevalence of respiratory conditions is anticipated to drive the expansion of the albuterol sulfate metered-dose inhalers market. Respiratory illnesses affect the lungs and airways, causing breathing difficulties and reduced oxygen intake. These conditions include asthma, chronic obstructive pulmonary disease (COPD), pneumonia, bronchitis, and other lung infections. One of the major contributors to the increase in respiratory conditions is rising air pollution, which heightens exposure to harmful pollutants that irritate the airways and deteriorate lung function. Albuterol sulfate metered-dose inhalers help alleviate symptoms by relaxing airway muscles, enhancing airflow, and easing breathing. These inhalers provide immediate relief from wheezing, coughing, and shortness of breath. For example, according to the Australian Bureau of Statistics in December 2023, the prevalence of COPD in Australia increased from 2.4% in 2021 to 2.5% in 2022. Thus, the growing occurrence of respiratory conditions is fueling the demand for albuterol sulfate metered-dose inhalers.

Leading companies in the albuterol sulfate metered-dose inhalers market are prioritizing the development of advanced solutions, including generic inhalation products, to increase accessibility for individuals with chronic respiratory issues. These generic inhalers offer the same active ingredients, dosages, and therapeutic benefits as branded products but are typically more affordable. For instance, in May 2024, Amphastar Pharmaceuticals Inc., a U.S.-based pharmaceutical firm, obtained abbreviated new drug application (ANDA) approval from the Food and Drug Administration (FDA) for its albuterol sulfate inhalation aerosol. This product is designed to treat or prevent bronchospasm in patients aged four and older. It acts by relaxing the airway muscles, improving airflow, and providing fast relief from symptoms such as wheezing and difficulty breathing in asthma patients.

In March 2022, Sandoz Group AG, a Switzerland-based pharmaceutical company, acquired Coalesce Product Development Limited for an undisclosed sum. This acquisition is intended to enhance Sandoz's respiratory portfolio in both the U.S. and European markets. By leveraging Coalesce's expertise in drug delivery systems, Sandoz aims to expand its pipeline of complex respiratory therapies and improve access to high-quality treatment options. Coalesce Product Development Limited is a UK-based firm specializing in the design and development of medical devices, including albuterol sulfate metered-dose inhalers.

Major players in the albuterol sulfate metered dose inhalers market are AstraZeneca PLC, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Sandoz Group AG, Agilent Technologies Inc, AptarGroup Inc., Chiesi Farmaceutici S.p.A., Dr. Reddy's Laboratories, Cipla Limited, Mundipharma International Limited, Lupin Limited, Zydus Pharmaceuticals Inc, Recipharm, Nephron Pharmaceuticals Corporation, Perrigo Company plc, Vectura Group Limited, BioCare Group, Nanopharm Ltd., Prasco Laboratories.

North America was the largest region in the albuterol sulfate metered dose inhalers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in albuterol sulfate metered dose inhalers report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the albuterol sulfate metered dose inhalers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The albuterol sulfate metered dose inhalers market consists of sales of dry powder inhalers (DPIs), soft mist inhalers (SMIs), nebulizers, and aerosol Inhalers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Albuterol Sulfate Metered Dose Inhalers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on albuterol sulfate metered dose inhalers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for albuterol sulfate metered dose inhalers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The albuterol sulfate metered dose inhalers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Albuterol Sulfate Metered Dose Inhalers Market Characteristics

3. Albuterol Sulfate Metered Dose Inhalers Market Trends And Strategies

4. Albuterol Sulfate Metered Dose Inhalers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Albuterol Sulfate Metered Dose Inhalers Growth Analysis And Strategic Analysis Framework

6. Albuterol Sulfate Metered Dose Inhalers Market Segmentation

7. Albuterol Sulfate Metered Dose Inhalers Market Regional And Country Analysis

8. Asia-Pacific Albuterol Sulfate Metered Dose Inhalers Market

9. China Albuterol Sulfate Metered Dose Inhalers Market

10. India Albuterol Sulfate Metered Dose Inhalers Market

11. Japan Albuterol Sulfate Metered Dose Inhalers Market

12. Australia Albuterol Sulfate Metered Dose Inhalers Market

13. Indonesia Albuterol Sulfate Metered Dose Inhalers Market

14. South Korea Albuterol Sulfate Metered Dose Inhalers Market

15. Western Europe Albuterol Sulfate Metered Dose Inhalers Market

16. UK Albuterol Sulfate Metered Dose Inhalers Market

17. Germany Albuterol Sulfate Metered Dose Inhalers Market

18. France Albuterol Sulfate Metered Dose Inhalers Market

19. Italy Albuterol Sulfate Metered Dose Inhalers Market

20. Spain Albuterol Sulfate Metered Dose Inhalers Market

21. Eastern Europe Albuterol Sulfate Metered Dose Inhalers Market

22. Russia Albuterol Sulfate Metered Dose Inhalers Market

23. North America Albuterol Sulfate Metered Dose Inhalers Market

24. USA Albuterol Sulfate Metered Dose Inhalers Market

25. Canada Albuterol Sulfate Metered Dose Inhalers Market

26. South America Albuterol Sulfate Metered Dose Inhalers Market

27. Brazil Albuterol Sulfate Metered Dose Inhalers Market

28. Middle East Albuterol Sulfate Metered Dose Inhalers Market

29. Africa Albuterol Sulfate Metered Dose Inhalers Market

30. Albuterol Sulfate Metered Dose Inhalers Market Competitive Landscape And Company Profiles

31. Albuterol Sulfate Metered Dose Inhalers Market Other Major And Innovative Companies

32. Global Albuterol Sulfate Metered Dose Inhalers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Albuterol Sulfate Metered Dose Inhalers Market

34. Recent Developments In The Albuterol Sulfate Metered Dose Inhalers Market

35. Albuterol Sulfate Metered Dose Inhalers Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기